OOIR: Observatory of International Research

Papers

(The median citation count of American Journal of Psychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Translational Mechanistic Biomarkers for the 21st Century	422
Reports to the Membership	409
Cognitive Remediation in Schizophrenia Spectrum Illness: Evidence for Treatment Persistence	324
Reviewers for The American Journal of Psychiatry	179
Racial and Ethnic Bias in the Diagnosis of Alcohol Use Disorder in Veterans	168
Beyond Feared Outcomes: Exploring Sensory Phenomena as a Novel Therapeutic Target for OCD	165
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials	144
Correction to Deligiannidis et al.	125
Examining and Modulating Neural Circuits in Psychiatric Disorders With Transcranial Magnetic Stimulation and Electroencephalography: Present Practices and Future Developments	122
Correcting Overestimations in Self-Harm Visit Data: Response From Bommersbach and Colleagues	111
Behavior as Physiology: How Dynamical-Systems Theory Could Advance Psychiatry	97
Reducing Duration of Untreated Psychosis: The Neglected Dimension of Early Intervention Services	95
Opioid Use Disorder: Pernicious and Persistent	93
Scientific Advances Supporting New and Improved Treatment Strategies in Psychiatry	92
Is Poorly Assisted Psilocybin Treatment an Increasing Risk?	89
The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study	88
Rethinking the First Episode of Schizophrenia: Identifying Convergent Mechanisms During Development and Moving Toward Prediction	87
“Closing the Loop” With Transcranial Electrical Stimulation for Depression	85
COVID-19 and Stress-Related Disorders	82
Structural Racism and the Imperative to Eliminate Mental Health Disparities	78
Can You Feel the Burn? Using Neuroimaging to Illuminate the Mechanisms of Mindfulness Interventions for Pain	78
Correction to Gray et al.	76
APA Council Reports	73
Update to Editors’ Disclosures	72
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	72

Perinatal Mental Health: Advances and Opportunities	71
The Impact of Alcohol and Other Substance Use Disorders on Mortality in Patients With Eating Disorders: A Nationwide Register-Based Retrospective Cohort Study	71
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	70
Functional Connectome Prediction of Anxiety Related to the COVID-19 Pandemic	70
Auditory Oddball Responses Across the Schizophrenia-Bipolar Spectrum and Their Relationship to Cognitive and Clinical Features	69
Neural Substrates of Vulnerability to Anxiety in Response to Stressful Life Events: A COVID-19 Study	65
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	64
Hitting the Target of Image-Guided Psychiatry?	64
Better Evidence for Pharmacological Maintenance Treatment in Nonaffective Psychoses: Implications for Relapse Prevention	63
The Long-Term Relationship Between Cannabis and Heroin Use: An 18- to 20-year Follow-Up of the Australian Treatment Outcome Study (ATOS)	61
2022 Annual Meeting: President-Elect Address	59
Distinguishing the Effects of Lead-Time Bias and Duration of Untreated Psychosis	57
2024 Annual Meeting: Presidential Address	55
Using the Power of a Giant Wisely: Confirming Inflammation in Depression	55
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	54
Treating Pathologies of the Will	54
Mental Health Disparities Research: An Introduction to New Directions	54
Prevalence and Correlates of Cannabis Use and Cannabis Use Disorder Among U.S. Veterans: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III)	52
Highlights From the Residents’ Journal: June 2023	52
The Invisible Children: Is the Glass Half Full or Half Empty?	52
The American Journal of Psychiatry’s Efforts Toward Eliminating Racism, Social Injustice, Health Care Inequities, and Publication Biases	52
Healing, Harms, and Humility: Expanding the Scope of Psychedelic-Assisted Psychotherapy Research	51
Toward Translatable Biomarkers of Psychedelic-Induced Neuroplasticity	50
Subcortical Brain Alterations in Carriers of Genomic Copy Number Variants	49
From Soldier’s Heart to Shared Genetic Risk: PTSD and Cardiovascular Disease	46
Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps	46
Trends in Prevalence of Cannabis Use Disorder Among U.S. Veterans With and Without Psychiatric Disorders Between 2005 and 2019	46
Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration	46
Decoding Shared Versus Divergent Transcriptomic Signatures Across Cortico-Amygdala Circuitry in PTSD and Depressive Disorders	46
Neurobiological Correlates of Change in Adaptive Behavior in Autism	46
Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul	45
Correction to Krakowski et al.	45
Predictors of Suicide Attempt Within 30 Days After First Medically Documented Suicidal Ideation in U.S. Army Soldiers	44
Evaluating Associations Between Cannabis and Heroin Use	44
The Trifecta of Misery and Disease Vulnerability: Poverty, Childhood Maltreatment, and Inflammation	44
ADHD and ASD: Time to Split or Lump?	44
Association of Neural Reward Circuitry Function With Response to Psychotherapy in Youths With Anxiety Disorders	44
Growing Up With ADHD Symptoms: Smooth Transitions or a Bumpy Course?	41
Ubiquitous Dopamine Deficit Hypotheses in Cocaine Use Disorder Lack Support	41
Highlights From the Residents’ Journal: December 2021	41
Broadening the Parameters of Clinical High Risk for Psychosis	40
Race-Related Disparities in Childhood Adversity, Trauma, and Stress-Related Psychopathology	40
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	39
Older Adults are at Heightened Risk of the Effects of Cannabis Use	38
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	37
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial	36
Effect of Experimental Manipulation of the Orbitofrontal Cortex on Short-Term Markers of Compulsive Behavior: A Theta Burst Stimulation Study	36
Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits	35
Depression and Schizophrenia: Sleep, Medical Risk Factors, Biomarkers, and Treatment	35
Depression: Factors Contributing to Risk and Therapeutic Insights	34

More Than Social Stigma Meets the Eye: The Inherent Struggle of Sexual and Gender Identity Development Across the Lifespan	34
When You Don’t Feel Right Inside: Homeostatic Dysregulation and the Mid-Insular Cortex in Psychiatric Disorders	34
Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress	34
Association of Inflammatory Activity With Larger Neural Responses to Threat and Reward Among Children Living in Poverty	34
PTSD, Phobias, Suicide Attempts, and Psychiatric Vulnerabilities	33
Anterior Insula–Associated Social Novelty Recognition: Pivotal Roles of a Local Retinoic Acid Cascade and Oxytocin Signaling	32
Polygenic Scores in Psychiatry: On the Road From Discovery to Implementation	32
A Longitudinal Study of Resting-State Connectivity and Response to Psychostimulant Treatment in ADHD	32
Disrupted Dorsal Mid-Insula Activation During Interoception Across Psychiatric Disorders	32
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	31
Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study	31
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	31
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	30
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	30
Intentional Drug Overdose Deaths in the United States	29
Persistent Dissociation and Its Neural Correlates in Predicting Outcomes After Trauma Exposure	29
Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape	29
Cell-Type-Specific Impact of Glucocorticoid Receptor Activation on the Developing Brain: A Cerebral Organoid Study	29
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	28
Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder	28
Optimizing the Treatment of Late-Life Depression	28
Association of Cannabis Use–Related Predictor Variables and Self-Reported Psychotic Disorders: U.S. Adults, 2001–2002 and 2012–2013	28
Vaccines as Immunotherapies for Substance Use Disorders	28
Understanding the Efficacy and Mechanism of Action of a Dextromethorphan-Bupropion Combination: Where Does It Fit in the NMDA Versus mu-Opioid Story?	28
Translational Neuroscience Approaches to Understanding Autism	27
Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects	27
Racial Disparities in Adversity During Childhood and the False Appearance of Race-Related Differences in Brain Structure	27
Safety of Antipsychotic Polypharmacy Versus Monotherapy in a Nationwide Cohort of 61,889 Patients With Schizophrenia	27
rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches	27
Recapitulation of Perturbed Striatal Gene Expression Dynamics of Donors’ Brains With Ventral Forebrain Organoids Derived From the Same Individuals With Schizophrenia	26
Prevalence and Penetrance of Rare Pathogenic Variants in Neurodevelopmental Psychiatric Genes in a Health Care System Population	26
Mindfulness-Oriented Recovery Enhancement for Veterans and Military Personnel on Long-Term Opioid Therapy for Chronic Pain: A Randomized Clinical Trial	26
Looking Through a Fog: What Persistent Derealization Can Teach Us About PTSD	26
Developmental Pathways and Clinical Outcomes of Early Childhood Psychotic Experiences in Preadolescent Children at Familial High Risk of Schizophrenia or Bipolar Disorder: A Prospective, Longitudinal	25
Psychotropic Drug–Related Weight Gain and Its Treatment	25
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry	25
Antidepressants and Bipolar Disorder: The Plot Thickens	25
Predictors of Substance Use Initiation by Early Adolescence	24
Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis	24
Association Between Intrauterine System Hormone Dosage and Depression Risk	24
Neuroimaging Biomarkers in Schizophrenia	24
Association of Cortico-Striatal Engagement During Cue Reactivity, Reappraisal, and Savoring of Drug and Non-Drug Stimuli With Craving in Heroin Addiction	24
The Prehistory of Psychiatric Genetics: 1780–1910	24
Anxiety, Depression, and Suicide in Youth	23
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia	23
Psychedelics as Transformative Therapeutics	23
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts	23
Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial	23
Attention Bias Modification Treatment Versus a Selective Serotonin Reuptake Inhibitor Or Waiting List Control for Social Anxiety Disorder: A Randomized Clinical Trial	22
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?	22
Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition	22
Positioning rTMS Within a Sequential Treatment Algorithm of Depression	22
Childhood Maltreatment and Mental Health Problems: A Systematic Review and Meta-Analysis of Quasi-Experimental Studies	22
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	22
Mood Disorders and Outcomes of COVID-19 Hospitalizations	22
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now	22
Highlights From the Residents’ Journal: June 2022	21
Highlights From Residents’ Journal: June 2021	21
APA Council Reports	21
Treatments for Depression in Bipolar II Disorder	21
A Comprehensive Multilevel Analysis of the Bucharest Early Intervention Project: Causal Effects on Recovery From Early Severe Deprivation	20
An Extended Swedish Adoption Study of Anxiety Disorder and Its Cross-Generational Familial Relationship With Major Depression	20
Highlights From the Residents’ Journal: September 2021	20
Polygenic Risk Scores and Genetics in Psychiatry	20
Comment on “Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids”: Response to Rubinow et al.	20
Comment on “Understanding the Clinical Effects and Mechanisms of Action of Neurosteroids”	19
Corrigendum to Morley et al.	19
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek	19
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use	19
Correction to Poirot et al.	19
Clarifying Confounder Variables and Cross-Sectional Power to Make Causal Conclusions About Race, Adversity, and Brain Differences	19
Early-Onset Psychosis and Autism Spectrum Disorder: Similar Rates of Deleterious Copy Number Variants, Yet Diverse Phenotypic Manifestations	19
Sexual Orientation and Suicidal Behavior: Is It Getting Better?	19
Sex-Specific Distributed White Matter Microarchitectural Alterations in Preadolescent Youths With Anxiety Disorders: A Mega-Analytic Study	18
CBT for Prolonged Grief in Children and Adolescents: A Randomized Clinical Trial	18
Applying Functional Imaging to Clinical Practice: Are We Making Progress Toward Its Promise?	18
A Randomized Clinical Trial of Prolonged Exposure Therapy With and Without Topiramate for Comorbid PTSD and Alcohol Use Disorder	18
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	18
Another Step Toward the Prediction of Antipsychotic Treatment Response Using Functional Connectivity	18
Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study	17

Putting Genetics to Work in the Psychiatric Clinic	17
The Influence of Parenting on Callous-Unemotional Traits and the Implications for the Causes and Treatment of Conduct Disorder	17
Neurodevelopmental and Neurodegenerative Illnesses: Autism, Fragile X Syndrome, Parkinson’s Disease, and Dementia	17
Replicating Predictive Cluster-Based Imaging Biotypes After Trauma: A Bridge Too Far?	17
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	16
The First Large GWAS Meta-Analysis for Postpartum Depression	16
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis	16
Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample	16
Correction to Webb et al.	16
Theta Burst TMS Technology: Great Promise and a Lot to Learn	16
Points that Need Attention in Early Auditory Information Processing Research in Schizophrenia	16
Effects of County-Level Opioid Dispensing Rates on Individual-Level Patterns of Prescription Opioid and Heroin Consumption: Evidence From National U.S. Data	16
Identifying and Reducing Bias in Genome-Wide Association Studies of Alcohol-Related Traits	16
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder	15
Structural Racism and Risk of Schizophrenia	15
Neglect of Adverse Effects in Treatment Guidelines for Depression	15
Using Medical Records to Investigate the Genetics of Treatment-Resistant Depression Across Health Care Systems	15
Pathogenic Variants and Ascertainment: Neuropsychiatric Disease Risk in a Health System Cohort	14
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability	14
Correction to Cruceanu et al.	14
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	13
Highlights From the Residents’ Journal: March 2024	13
Subcortical Anatomy in Neurogenetic Disorders: New Findings and Future Questions	13
Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Inve	13
Vivian B. Pender, M.D., 148th President, 2021–2022	13
Polygenic Scores and Onset of Major Mood or Psychotic Disorders Among Offspring of Affected Parents	13
2024 Annual Meeting: CEO and Medical Director’s Address	13
2022 Articles of Import and Impact	13
An Insula-Enriched Regulator of Retinoic Acid Marks a New Intersection in the Neural Circuitry of Mouse Social Behavior	13
Reviewers for The American Journal of Psychiatry	13
Highlights From the Residents’ Journal: September 2024	13
Acute Stress, Traumatic Brain Injury, and Dissociation: Response to Simeon	13
Psychotherapy’s Role for Treatment-Resistant Depression?	13
Focusing on Substance Use Disorders, Opioids, and Craving	13
Is Violent Suicide Molecularly Distinct?	13
Highlights From the Residents’ Journal: September 2023	13
Aripiprazole Augmentation as a Treatment for Clozapine-Induced Weight Gain: Response to Kramer and Velicu	13
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis	12
Through a Developmental Lens: Emerging Insights to Understand and Treat Pediatric PTSD	12
A Novel Psychosocial Intervention for Motivational Negative Symptoms in Schizophrenia: Combined Motivational Interviewing and CBT	12
Evolution, Emotion, and Episodic Engagement	12
Are We There Yet? Predicting Conversion to Psychosis Using Machine Learning	12
Mechanisms of Action of Ketamine and Esketamine	12
With Apologies to Monty Python: Is Every Cell Sacred?	11
Substance Use Disorders	11
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience	11
Centering Agency and Choice in Moving Toward Social Justice in Mental Health: Reflections on Childhood Maltreatment, Psychiatric Symptoms, and Homelessness	11
Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders	11
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research	11
Charting the Neural Pathways From Discrimination to Mental Health Disparities	11
Suicide and the Menstrual Cycle	11
Varenicline as a First-Line Treatment for Individuals With Current Major Depressive Disorder Who Smoke Cigarettes	10
Using Genetically Diverse Rats to Identify Individual Differences in Addiction-Related Behaviors and Brain Activity	10
Correcting Overestimations in Self-Harm Visit Data	10
Intermittent Theta Burst Stimulation With Adjunctive D-Cycloserine for Obsessive-Compulsive Disorder: A Randomized Clinical Trial	10
A Fresh Look at the Allostasis Theory of Addiction	10
Irremediable Psychiatric Suffering, a Potential Indication for Psilocybin Treatment	10
From Awareness to Action: An Urgent Call to Address the Inadequacy of Treatment for Anorexia Nervosa	9
Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder	9
Cerebral Small Vessel Disease Progression and the Risk of Dementia: A 14-Year Follow-Up Study	9
Maternal Perinatal Stress Trajectories and Negative Affect and Amygdala Development in Offspring	9
New Insights Into Psychotic Disorders	9
Brain Imaging in Psychiatry: Time to Move From Regions of Interest and Interpretive Analyses to Connectomes and Predictive Modeling?	9
Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition	9
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population	9
Transition From Substance-Induced Psychosis to Schizophrenia Spectrum Disorder or Bipolar Disorder	9
The Evolving Nexus of Sleep and Depression	8
Subcortical Brain Development in Autism and Fragile X Syndrome: Evidence for Dynamic, Age- and Disorder-Specific Trajectories in Infancy	8
Highlights from the Residents’ Journal: December 2022	8
Distinct Behavioral Profiles and Neuronal Correlates of Heroin Vulnerability Versus Resiliency in a Multi-Symptomatic Model of Heroin Use Disorder in Rats	8
The Devastating Clinical Consequences of Child Abuse and Neglect: Increased Disease Vulnerability and Poor Treatment Response in Mood Disorders	8
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	8
Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women	8
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial	8
Understanding the Value and Limitations of MRI Neuroimaging in Psychiatry	8
Psychiatric Genetics in Clinical Practice: Essential Knowledge for Mental Health Professionals	8
Differential Patterns of Delayed Emotion Circuit Maturation in Abused Girls With and Without Internalizing Psychopathology	8
Performance Measurement for Opioid Use Disorder Medication Treatment and Care Retention	8
Increased Inflammation in Depression: A Little in All, or a Lot in a Few?	8
Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity	7
Effects of Gabapentin on Dorsal Anterior Cingulate Cortex GABA and Glutamate Levels and Their Associations With Abstinence in Alcohol Use Disorder: A Randomized Clinical Trial	7
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia	7
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	7
Let’s Be Clear That “Autism Spectrum Disorder Symptoms” Are Not Always Related to Autism Spectrum Disorder	7
The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons	7
The Intergenerational Transmission of Anxiety Disorders and Major Depression	7
Long-Term Antipsychotic Use and the Benefit-to-Harm Balance: More on the Risk of Relapse	7
Anticholinergic Burden and Cognitive Function in Psychosis: A Systematic Review and Meta-Analysis	7
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	7
Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial	7
The Risk of Overdose With Concomitant Use of Z-Drugs and Prescription Opioids: A Population-Based Cohort Study	7
Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: An Open-Label Pilot Study	7
Estimating Multimodal Structural Brain Variability in Schizophrenia Spectrum Disorders: A Worldwide ENIGMA Study	7
Insights From Genetic, Neuroimaging, and Behavioral Neuroscience Studies	6
Insights Into Improving Clinical Outcomes Across Psychiatric Disorders and Medical Comorbidities	6